8-KItem 4.01 · Accountant ChangeItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
RESMED INC (RMD)

ResMed Names Carol Burt Lead Director as Ron Taylor Plans Board Retirement

Filed with the SEC on · Summarized by InvestorsBot

ResMed said Carol Burt will become lead director on November 15, 2026, succeeding Ron Taylor, who will retire from the board after more than 21 years of service. Taylor will not stand for reelection at ResMed’s annual meeting, expected on November 18, 2026, and said his retirement is not related to any disagreement with the company.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from RESMED INC

ResMed starts $450 million accelerated share repurchase with Citibank

8-K · September 1, 2026

ResMed appoints Carol Burt as lead director as Ron Taylor plans retirement

8-K · August 17, 2026

ResMed replaces KPMG with PwC as independent auditor

8-K · August 17, 2026

ResMed CEO Michael Farrell sells $1.03M in stock

Form 4 · Insider Trade · August 11, 2026

ResMed filed an 8‑K (Item 9.01) attaching a press release dated Jan 29, 2026 reporting results of…

8-K · January 29, 2026

ResMed ($RMD) board declared a quarterly cash dividend of $0.60/share.

8-K · January 29, 2026